Mon, October 18, 2021
Sun, October 17, 2021
Fri, October 15, 2021
Thu, October 14, 2021
Wed, October 13, 2021
Tue, October 12, 2021
Mon, October 11, 2021
Sun, October 10, 2021
Fri, October 8, 2021
Thu, October 7, 2021
Wed, October 6, 2021

Reni Benjamin Maintained (ALLO) at Buy with Decreased Target to $27 on, Oct 12th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-27-on-oct-12th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Reni Benjamin of JMP Securities, Maintained "Allogene Therapeutics, Inc." (ALLO) at Buy with Decreased Target from $53 to $27 on, Oct 12th, 2021.

Reni has made no other calls on ALLO in the last 4 months.



There are 4 other peers that have a rating on ALLO. Out of the 4 peers that are also analyzing ALLO, 2 agree with Reni's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Benjamin Burnett of "Stifel" Downgraded from Strong Buy to Hold on, Friday, October 8th, 2021
  • Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $20 on, Friday, October 8th, 2021


These are the ratings of the 2 analyists that currently disagree with Reni


  • Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $45 on, Friday, October 8th, 2021
  • Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $36 on, Friday, September 24th, 2021

Publication Contributing Sources